Tag: GCP compliance

Documenting Interim Analysis Plans in Protocol, SAP and Charter

Posted on By digi

Documenting Interim Analysis Plans in Protocol, SAP and Charter In the dynamically evolving landscape of clinical research, the necessity of interim analyses has become increasingly acknowledged by regulatory bodies and sponsors alike. Conducting interim analyses allows for the monitoring of data throughout the lifecycle of a clinical trial, potentially informing decisions regarding safety, efficacy, and…

Read More “Documenting Interim Analysis Plans in Protocol, SAP and Charter” »

Interim Analyses & Alpha Spending

Building Surveillance Capability in Lean Clinical Development Teams

Posted on By digi

Building Surveillance Capability in Lean Clinical Development Teams In the context of modern clinical trials, particularly those governed by ICH-GCP, FDA, EMA, and MHRA regulations, the need for robust surveillance capabilities has never been more critical. In this guide, we will delve into how to build surveillance capability within lean clinical development teams, focusing on…

Read More “Building Surveillance Capability in Lean Clinical Development Teams” »

Statistical Data Surveillance

Issue Management in RBM: From Signal to Actionable Resolution

Posted on By digi

Issue Management in RBM: From Signal to Actionable Resolution Risk-Based Monitoring (RBM) in clinical trials offers considerable advantages in ensuring the safety and efficacy of treatments while optimizing resource use. Effective issue management is crucial within this framework, necessitating a structured approach that allows clinical operations, regulatory affairs, and medical affairs professionals to identify, evaluate,…

Read More “Issue Management in RBM: From Signal to Actionable Resolution” »

Issue Management & Escalation Paths

Metrics for Standards Adoption, Rework and Submission Findings

Posted on By digi

Metrics for Standards Adoption, Rework and Submission Findings Metrics for Standards Adoption, Rework and Submission Findings In the realm of clinical trials, data management is a critical component that directly impacts the efficiency and accuracy of study results. The adoption of standardized data formats, particularly those established by the Clinical Data Interchange Standards Consortium (CDISC),…

Read More “Metrics for Standards Adoption, Rework and Submission Findings” »

Data Standards (CDISC: SDTM, ADaM)

Data Integrity in Clinical Trials: Applying ALCOA++ and 21 CFR Part 11

Posted on By digi

Data Integrity in Clinical Trials: Applying ALCOA++ and 21 CFR Part 11 Data integrity is paramount in clinical trials, underpinning the reliability of results and the safety of patients. This article will provide a comprehensive step-by-step guide for clinical research professionals to understand and implement the principles of ALCOA++ and the regulatory requirements of 21…

Read More “Data Integrity in Clinical Trials: Applying ALCOA++ and 21 CFR Part 11” »

Data Integrity (ALCOA++, 21 CFR Part 11)

Adaptive Enrichment and Sample Size Re-Estimation at Interim

Posted on By digi

Adaptive Enrichment and Sample Size Re-Estimation at Interim Adaptive Enrichment and Sample Size Re-Estimation at Interim The ever-evolving landscape of clinical trials necessitates a robust and flexible approach to data analysis. This is particularly true in the context of interim analyses, where decisions must be made based on incomplete data. This step-by-step guide focuses on…

Read More “Adaptive Enrichment and Sample Size Re-Estimation at Interim” »

Interim Analyses & Alpha Spending

Case Studies: Surveillance-Driven Interventions That Protected Patients

Posted on By digi

Case Studies: Surveillance-Driven Interventions That Protected Patients Case Studies: Surveillance-Driven Interventions That Protected Patients The landscape of clinical trials is continually evolving, particularly with the rise of surveillance-driven interventions that are crucial for protecting patient safety and data integrity. This guide provides a comprehensive overview of the effective implementation of these interventions in the context…

Read More “Case Studies: Surveillance-Driven Interventions That Protected Patients” »

Statistical Data Surveillance

Tools and Platforms for Automated Statistical Data Surveillance

Posted on By digi

Tools and Platforms for Automated Statistical Data Surveillance Tools and Platforms for Automated Statistical Data Surveillance The landscape of clinical trials is evolving, particularly in the realm of statistical data surveillance. In recent years, technologies and methodologies have emerged to allow for effective remote monitoring and oversight of clinical trials, including those focusing on ankylosing…

Read More “Tools and Platforms for Automated Statistical Data Surveillance” »

Statistical Data Surveillance

Training Clinical and Data Teams on CDISC Concepts and Value

Posted on By digi

Training Clinical and Data Teams on CDISC Concepts and Value In the ever-evolving landscape of clinical research, understanding the principles and applications of the Clinical Data Interchange Standards Consortium (CDISC) is paramount for professionals involved in ankylosing spondylitis clinical trials. This article aims to provide a comprehensive step-by-step guide for training clinical and data teams…

Read More “Training Clinical and Data Teams on CDISC Concepts and Value” »

Data Standards (CDISC: SDTM, ADaM)

Integrating Data Standards Into Protocol, SAP and CRF Design

Posted on By digi

Integrating Data Standards Into Protocol, SAP and CRF Design Integrating Data Standards Into Protocol, SAP and CRF Design In the ever-evolving landscape of clinical research, ensuring data integrity and standardization is paramount. This article delves into the integration of data standards, specifically focusing on the Clinical Data Interchange Standards Consortium (CDISC) and its vital components…

Read More “Integrating Data Standards Into Protocol, SAP and CRF Design” »

Data Standards (CDISC: SDTM, ADaM)